| Clearing the smoke around medical marijuana. | |
| | |
MedLine Citation:
|
PMID: 22089341 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The hazy world of "medical marijuana" continues to cry out for clear data on which to base medical decision making and rational policy design. In this issue of Clinical Pharmacology & Therapeutics, Abrams and colleagues report that vaporized cannabis does not meaningfully affect opioid plasma levels and may even augment the efficacy of oxycodone and morphine in patients with chronic non-cancer pain. This Commentary considers the implications of this work for clinical practice and further research initiatives. |
| | |
Authors:
|
M A Ware |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical pharmacology and therapeutics Volume: 90 ISSN: 1532-6535 ISO Abbreviation: Clin. Pharmacol. Ther. Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-11-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372741 Medline TA: Clin Pharmacol Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 769-71 Citation Subset: AIM; IM |
Affiliation:
|
Department of Family Medicine and Department of Anesthesia, McGill University, Montreal, Quebec, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Model-based meta-analysis for comparative efficacy and safety: application in drug development and b...
Next Document: PON1 Q192R and Clopidogrel: A Case of the Winner's Curse or Inadequate Replication?